| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Stoke Therapeutics, Inc. (STOK) has 15 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. STOK is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 3.91M | $124.49M | - | |
| CEO | 380.0K | $12.11M | - | |
| Dir | 283.3K | $9.03M | - | |
| Other | 118.7K | $3.78M | - | |
| Dir | 110.9K | $3.53M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 1, 2024 | Ticho Barry52 | Chief Medical Officer | Sale+OE | 10,000 | $12.68 | $126,803.00 | -80.1% | -14.5% | +133.6% | |
| Oct 1, 2024 | Ticho Barry52 | Chief Medical Officer | Sale+OE | 10,000 | $12.06 | $120,648.00 | -80.1% | -12.7% | +90.7% | |
| Sep 19, 2024 | Skorpios Trust | 10% Owner | Sell | 1,937,500 | $14.05 | $27,221,875.00 | -17.9% | -26.6% | +51.3% | |
| Sep 3, 2024 | Ticho Barry52 | Chief Medical Officer | Sale+OE | 10,000 | $14.95 | $149,480.76 | -64.2% | -19.7% | +31.5% | |
| Aug 1, 2024 | Ticho Barry52 | Chief Medical Officer | Sale+OE | 10,000 | $14.58 | $145,843.00 | -80.1% | -15.1% | -12.3% | |
| Jul 2, 2024 | Nash Huw M.81 | Chief Business Officer | Sell | 2,500 | $13.11 | $32,778.87 | -98.7% | -4.2% | -10.0% | |
| Jul 1, 2024 | Ticho Barry52 | Chief Medical Officer | Sale+OE | 10,000 | $13.75 | $137,458.00 | -80.1% | -11.4% | -16.0% | |
| Jun 3, 2024 | Ticho Barry52 | Chief Medical Officer | Sale+OE | 10,000 | $15.22 | $152,185.43 | -66.3% | -2.9% | -29.6% | |
| May 20, 2024 | Nash Huw M.81 | COO &Cbo | Sale+OE | 50,000 | $15.39 | $769,500.00 | -100% | -7.8% | -37.6% | |
| May 20, 2024 | Allan Jonathan46 | General Counsel &Corp Sec | Sale+OE | 8,599 | $15.04 | $129,327.24 | -76.8% | -7.8% | -37.6% |